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1. Introduction 
Cysteine plays an important role in the regulation of redox chemistry and gene expression 
and is essential in the structural and macromolecular organisation of proteins. Thiol 
oxidation leads to misfolding and the influencing of the protein function (Buczek et al., 
2007). In our experiments, we have identified an oxidised cytoskeletal protein actin involved 
in the rearrangement of filament in the cells, leading to cellular apoptosis (Wang et al., 2010). 
Redox signalling can be relayed through intramolecular or intermolecular disulphide 
formation (Li et al., 2005).  
Redox proteomics is an emerging branch of proteomics aimed at detecting and analysing 
redox-based changes within the proteome in different redox statuses (D'Alessandro et al., 
2011). For this reason, several experimental approaches have been developed for the 
systematic characterisation of thiol proteome. One major limit in such an analysis is the 
chemical labile nature of Cys redox modifications; thus - basically - two critical steps are 
needed in analysing the thiol proteome, which consists of a temporary trapping of free 
thiols and their subsequent reduction (Avellini et al., 2007; Butterfield and Sultana, 2007). 
2. Analysis of redox-sensing and signalling thiols 
The cysteine proteome includes 214000 Cys with thiols and other forms. A relatively small 
subset functions in cell signalling, while a large number functions in response to the redox 
state. The former are redox-signalling thiols and the latter are defined as redox-sensing 
thiols (Dietz, 2003; Jones and Go, 2011; Sen, 1998; Sen, 2000). Some proteins contain Cys 
residues that are regulatory: their oxidation leads to misfolding and the influencing of 
protein activity. Several cytoskeletal proteins have been identified to be oxidative sensitive. 
Specific Cys residues’ oxidation in these proteins has been identified. Among them, actin is 
the main component of the microfilament cytoskeleton and exists as monomeric G-actin, 
which can polymerise into filamentous F-actin upon extracellular stimuli. The constant and 
rapid reorganisation of the actin microfilament system is highly regulated (Carlier, 1991). A 
growing body of evidence indicates that the actin system is one of the most sensitive 
constituents of the cytoskeleton to oxidant attack. Recent redox proteomics studies have 
detected actin as the most prominent protein oxidised in response to the exposure of cells to 
oxidants (Fiaschi et al., 2006). The direct redox regulation of actin in vivo is one of the most 
important processes regulating the dynamics of the microfilament system. Trx1 was 
identified as interacting with actin and protecting the actin cytoskeleton from oxidative 
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stress. Moreover, actin can be kept at a reduced status, even at a higher concentration of 
H2O2 stimulation, under the protection of Trx1. Trx1 is expressed ubiquitously in 
mammalian cells and contains a conserved Cys-Gly-Pro-Cys active site (Cys 32 and Cys 35) 
that is essential for the redox regulatory function (Carlier, 1991). In addition to the 
conserved cysteine residues in the active site, three additional structural cysteine residues 
(Cys 62, Cys 69, and Cys 73) are present in the structure of the human Trx1 (Nishiyama et 
al., 2001). Trx1 is S-nitrosylated on Cys 69, which is required for scavenging ROS and 
preserving the redox regulatory activity, and contribute to the protein’s anti-apoptotic 
functions (Haendeler et al., 2002). Cys 73 residue is involved in dimerisation of Trx1 via an 
intermolecular disulphide bond formation between Cys 73 of each monomer in the oxidised 
state. The biological function of the Cys 62 and Cys 69 residues in the non-active domain 
remains to be fully elucidated. Some studies suggest that the formation of a disulphide bond 
between Cys 62 and Cys 69 created a way to transiently inhibit Trx1 activity for redox 
signalling under oxidative stress (Watson et al., 2003). A new role for Cys 62 - although it is 
not a key site that is involved in cellular redox regulation - plays an important role in 
mediating its interaction with actin. This interaction disappeared with the increasing 
concentration of H2O2 stimulation. One possible reason is that the intramolecular disulphide 
bond formation inhibits the activity of Trx1. Different H2O2 concentrations have different 
oxidative effects of functional relevance, leading to dimer formation, glutathionylation and 
depolymerisation of the actin system, depending on the location of the actin molecules, the 
source of the oxidant and the availability of surrounding reducing systems (Lassing et al., 
2007). Many studies on oxidative stress have shown that both Cys 374 and Cys 272 of -actin 
are highly reactive to oxidising agents. Chemical modification of Cys 374 affects 
polymerization ability and profilin binding (Dalle-Donne et al., 2007). The intracellular thiol 
homeostasis is maintained by the thioredoxin and glutaredoxin systems, which utilise 
NADPH as reducing equivalents in order to reduce proteins (Kalinina et al., 2008). Thus, 
oxidative modification may be restored by these redoxins and glutaredoxins. In vivo, the 
direct redox control of actin by Trx1 could be one of the most important processes 
regulating the dynamics of the microfilament system. It has been demonstrated that Trx1 
could protect cells from apoptosis by the thiol oxidoreductase activity (Damdimopoulos et 
al., 2002; Poerschke and Moos, 2011; Smeets et al., 2005). Moreover, reduced Trx1 forms a 
complex with the apoptosis signalling regulating kinase-1 (ASK1) and protects cells from 
apoptosis by inhibiting ASK1 (Saitoh et al., 1998). Cys 62 in Trx1 plays an important role in 
protecting cells from apoptosis, independently of its role in the enzyme active site. Trx1, by 
binding to actin and regulating its dynamics, could protect cells from apoptosis(Wang et al., 
2010). The results of oxidative stress on protein thiols and disulphides in Mytilus edulis 
revealed by proteomics also suggest that actin and protein disulphide isomerase are redox 
targets (McDonagh and Sheehan, 2008). Actin was also identified by affinity 
chromatography assay to be a Trx1 target in eukaryotic unicellular green algae (Saitoh et al., 
1998). Both actin and Trx1 are evolutionarily conserved proteins, the protection of actin from 
oxidative insult by the TRX system could be a universal regulatory mechanism. 
Many crucial signalling pathways utilise the reversible oxidation and reduction of cysteine 
thiols as a molecular switch. Redox-based regulation of gene expression has emerged as a 
fundamental regulatory mechanism in cell biology. Some proteins have apparent redox-
sensing activity: electron flow through side-chain functional CH2-SH groups of conserved 
cysteinyl residues in these proteins accounts for their redox-sensing properties. Protein thiol 
groups with high thiol-disulphide oxidation potentials are likely to be redox-sensitive.  
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A class of signalling factors has been identified which uses cysteine residues in the 
conserved motifs (such as CXXC or CXXS) as redox-sensitive sulphydryl switches to 
modulate specific signal transduction cascades that have similar redox-sensitive sites 
(Lemaire et al., 2005). The identity of the amino acids separating the two cysteines in the 
CXXC motif and protein location influences the redox properties of CXXC-containing 
proteins - these proteins may serve as reductants or oxidants. TRX is a key molecule in the 
maintenance of the cellular redox balance. In addition to the cytoprotective action against 
oxidative stresses, it is involved in various cellular processes, including gene expression, 
signal transduction, proliferation and apoptosis (Klemke et al., 2008). Hepatopoietin (HPO) 
is a novel hepatotrophic growth factor, which is involved in the process of liver regeneration 
in rats, mice and humans (Francavilla et al., 1994; Hagiya et al., 1994). It belongs to the 
family essential for respiration and vegetative growth (ERV) 1/augmenter of liver 
regeneration (ALR). Both HPO and TRX have conserved CXXC motifs as their enzymatic 
active site. These cysteines in the redox regulatory domain are reactive and can be 
covalently linked to other proteins by forming disulphide bridges. It has been known that 
the family of FAD-dependent sulphydryl oxidase/quiescin-Q6-related genes contains 
thioredoxin (TRX) and yeast ERV1 domains (Hoober et al., 1999). If a composite protein is 
uniquely similar to two component proteins, no matter whether they are in the same species 
or not, the component proteins are most likely to interact or be involved in the same signal 
transduction (Marcotte et al., 1999a; Marcotte et al., 1999b). HPO is identified as functioning 
in conjunction with TRX by which it plays an important role in sensing the extracellular 
redox signals. 
Homologs of this family have been found in a large number of lower and higher eukaryotes 
and in some viruses. Recently, ALR was identified as a sulphydryl oxidase by its ability to 
oxidise thiol groups of protein substrates and the presence of an FAD moiety in the 
carboxyl-terminal domain and the formation of dimer in vivo (Hofhaus et al., 2003; Lisowsky 
et al., 2001). It has also been shown that the effect of HPO on the activator protein-1 (AP-1) is 
dependent on its sulphydryl oxidase activity. ERV2, a member of ERV1/ALR in yeast, is an 
essential element of the pathway for the formation of disulphide bonds within the 
endoplasmic reticulum. E10R, a viral member of the ERV1/ALR protein family, participates 
in a cytoplasmic pathway of disulphide bond formation (Senkevich et al., 2000) and is 
responsible for the oxidation of the viral G4L gene product, which is homologous to 
glutaredoxin. A common characteristic of the proteins in this family is that they are involved 
in the redox reaction by the regulation of disulphide bond formation.  
Two major mechanisms involving the reversible modification of amino acid side chains to 
modulate protein activity are phosphorylation/dephosphorylation by kinase and 
phosphatase systems and reduction/oxidation by thiol-dependent enzymes (Nakashima et 
al., 2002). Whereas many signalling processes involving phosphorylation are well-
understood in terms of the mechanisms and identities of participating enzymes, redox 
regulation of cellular processes remains a poorly characterised area. HPO directly interacted 
with TRX, by which the redox state of TRX was changed, and then its effects on the activity 
of AP-1 and NF-κB were potentiated. The transcription factors NF-κB and AP-1 have been 
implicated in the inducible expression of a variety of genes involved in responses to 
oxidative stress and cellular defence mechanisms (Xanthoudakis et al., 1992). A feature of 
NF-κB is that both oxidants as well as reductants are known to activate it (Byun et al., 2002; 
Jeon et al., 2003). Activation of NF-κB by TRX could be attributed to its reduced form for the 
overexpression of TRX caused activation of NF-κB and the degradation of IκB in the cytosol; 
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at the same time, the c-Jun NH2-terminal kinase (JNK) signalling cascade was also activated. 
However, some investigations have shown that the transient expression of TRX resulted in a 
pronounced inhibition of NF-κB-dependent transactivation in CAT assays. Our studies 
showed that when the COS7 cells were cotransfected with HPO and TRX, a part of TRX is 
oxidised in cells expressing TRX, but the DNA binding activity of NF-κB and its 
transactivation were increased. The results of yeast two-hybrid analysis demonstrate that 
the binding ability of HPO with HPO is higher than that of HPO with TRX, implying that 
under the stimulation of an oxidative signal HPO tended to be assembled into dimers. The 
direct transfer of oxidising equivalents by dithiol/disulphide exchange reactions can be 
demonstrated by the oxidisation of TRX by HPO in vivo and in vitro. We could infer that the 
oxidising equivalents’ flow might be from HPO to TRX and then to substrate proteins, 
leading to the change of the redox state of substrate protein and finally to affecting the 
activity of AP-1 or NF-κB. Recently, we have demonstrated that HPO can exist as a 
homodimer via disulphide bonds and that HPO has the capacity to form both homodimers 
and heterodimers with its alternatively spliced forms, which might contribute to the 
existence of various HPO compounds in hepatic cells. The HPO dimer still has sulphydryl 
oxidase activity and serves as an oxidant under oxidative conditions. These results imply 
that under oxidative stress conditions, intermolecular disulphide bonds formed within HPO 
could be transferred by a dithiol/disulphide exchange reaction to the active site of TRX and 
then to substrate proteins. In this sense, HPO links the redox chemistry of the cell to the 
formation of disulphide bonds within cytoplasm, while TRX acts as a mobile carrier of 
oxidising equivalents inducing the latter into nucleus to activate the expression of related 
genes. Two members of the ERV/ALR protein family (ERV2 and E10R) could use molecular 
oxygen directly to contribute oxidising equivalents for disulphide bond formation. Here, we 
found that another member of this family (HPO, as a FAD-linked sulphydryl oxidase) could 
also use reactive oxygen to generate disulphide bridges in protein substrate. 
HPO is assembled into a dimer under the stimulation of oxidants, such as H2O2 and 
diamide, and the HPO dimer could be dissociated into monomer by DTT both in vivo and in 
vitro. TRX, another component protein in Q6, is also sensitive to the alteration of the redox 
state by the change of its free thiols. These results support the assumption that both HPO 
and TRX are sensitive to the cellular redox state and involved in the modulation to it. 
TRX has been shown to interact directly with the apoptosis signal-regulating kinase 1 
(ASK1) by forming disulphide bridges and acting as a physiological inhibitor of ASK1 in 
stress-free cells (Saitoh et al., 1998). The interaction is dependent on the redox status of TRX 
and can be regulated by intracellular reactive oxygen species (ROS) levels. In particular, an 
increase in ROS concentration causes the dissociation of TRX from ASK. As a result, ASK1 
can undergo polymerisation, which corresponds to the active form of the enzyme. ASK1 has 
been suggested to activate the p38 and JNK upstream kinases, MKK3/6 and MKK4/7, 
respectively. We therefore speculate that the interaction between HPO and TRX might 
disrupt the interaction between TRX and ASK1. It is reduced but not oxidised thioredoxin 
that acts as a high affinity inhibitor of ASK1. When thioredoxin is oxidised by HPO in 
cytoplasm, it leads to the dissociation of TRX from ASK1 and polymerisation of ASK, it 
activates the stress-activated protein kinase pathway, and it promotes JNK activation and 
increases the activity of AP-1 and NF-κB. 
A comparison of HPO-specific redox components with those of other known pathways for 
disulphide bond formation suggests some interesting analogies. The upstream components 
of the three known pathways - namely E. coli DsbB, yeast ERO1p and ERV2p - are proteins 
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having two pairs of active cysteines each. In each case, the catalytic pair of cysteines 
interacts with ubiquinone, oxygen or another nonthiol electron acceptor forming a CXXC 
motif. The oxidative equivalents are then transferred to the second pair of cysteines on the 
same polypeptide chain, in the case of ERV2p, to the second subunit of a homodimer, and so 
is HPO. The second protein in the cascade of disulphide bond formation invariably is a 
thioredoxin-like protein - namely DsbA in E. coli, protein disulphide isomerase or its 
homologs in the yeast ER and the G4L thioredoxin-like protein in poxviruses. The HPO 
pathway therefore represents the first eukaryotic pathway for disulphide transmission in 
cytoplasm. 
The importance of these findings is that the redox signalling transduction is conducted by 
the thiol-disulphide cascade in cytoplasm of mammalian cells. Thus, the pathways of 
disulphide bond formation in such diverse systems appear to use the same general 
principles of thiol-disulphide transfer between protein components. In this sense, HPO 
serves as a signal factor in the regulation of AP-1 and NF-κB activity via its cysteine. Early in 
the course of liver regeneration initiation, the expression of HPO increases quickly so that 
the cellular milieu becomes highly oxidising and these conditions shift the thiol-disulphide 
equilibrium of cellular proteins, which may play an important role in the stimulation of 
signalling transduction for promoting hepatocyte proliferation. This issue also explains the 
important role of HPO in liver regeneration and the mechanisms found in the calcium-
dependent oxidation of TRX during cellular growth initiation. The rise in intracellular 
calcium induced by a growth factor binding to their receptor resulted in a marked 
conversion of reduced thioredoxin to the oxidised disulphide form. This apparent inhibition 
of thioredoxin reductase, coupled with the burst of H2O2 formation, leads to transient redox 
changes in cellular thiol proteins that may play an essential role in mitogen signal 
transduction. Thus, the relationship between HPO and TRX demonstrated by our results 
might shed new light on the signal transduction that oxidoreductase is involved in the 
processes of cell proliferation, apoptosis and organogenesis (Li et al., 2005). 
3. Proteomics studies to analyse the oxidation state of proteins 
3.1 Covalent modification to identify oxidation/nitrosylation of cysteine thiol groups 
To date, 2DE coupled with mass spectrometry (MS) is still the best separation tool for 
analysing redox-based protein changes. ROS/RNS caused covalent modifications to 
proteins, which makes it possible to reveal these changes by applying specific labelling. 
Among the many kinds of amino acid residues susceptible to oxidative stress, cysteine is 
one of the most sensitive. Its free thiol groups play an important role in regulating protein 
functions and are often the target of oxidative stress. So far, several approaches have been 
developed to analyse the thiol proteome. The main limit is the chemical labile nature of Cys 
redox modifications. So, there are two critical steps needed in analysing the thiol proteome, 
which consists in trapping and reducing of free thiols. TCA (trichloroacetic acid)-based 
acidification was often used to quench the thiol groups, and then cell permeable Cys-specific 
reagents such as the alkylating agents iodoacetamide (IAA) or N-ethylmaleimide (NEM) 
were used to label the free thiols. Some specific reducing agents can be used to detect 
specific forms of oxidation. For example, cysteine residues in the form of sulphenic acid are 
difficult to identify because of their unstable chemical nature; however, this has been 
achieved by the exclusive reduction of sulphenic acid by sodium arsenite or through its 
reaction with specific chemicals, such as dimedone. S-nitrosothiols are reduced by ascorbate, 
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whereas stronger reductants such as DTT reduce both nitrosothiols and disulphides (Jones 
and Go, 2011).  
3.2 Quantification of redox proteomics 
Several thiol-reactive reagents have been used to reveal the extent of Cys oxidation by 2DE 
gels, which include the IAM-derivatives 5-iodoacetamidofluorescein and Cys-specific 
fluorescent reagent monobromobimane. Differentials in the gel electrophoresis (DIGE) 
technique have been used to analyse the “redoxome” (Sethuraman et al., 2004). In this 
method, a set of fluorophores of similar molecular weights and chemical structures that 
differ according to their spectral features (absorption and emission wavelengths) were 
applied. NEM or IAM derivatives of cyanine (Cy3, Cy5) and DY-dyes were used in Redox-
DIGE. The limitation of the above method is that only abundant proteins are detected, often 
missing low amplitude proteins such as transcription proteins and regulatory proteins. One 
way solving this problem is to perform an upstream enrichment step for the oxidised 
protein-thiol fraction of the proteome using the biotin-switch method originally developed 
by Jaffrey et al. (Salsbury et al., 2008). Biotin-based strategies are largely used for the 
detection of S-glutathionylation and S-nitrosylation - two Cys modifications which occur 
extensively in diseases characterised by oxidative stress. 
Sethuraman et al. described the shotgun proteomic approach: isotope-coded affinity tag 
(ICAT) reagents were applied to quantify oxidant-sensitive protein thiols. This technique 
uses a certain type of marker which consists of three different parts: (i) a thiol-reactive 
compound (an iodoacetamide analogue), (ii) a linker containing either heavy or light 
isotopes, and (iii) a biotin tag for separation by avidin-coupled affinity chromatography. The 
principle of the ICAT approach in redox proteomics is that only free thiols are modified by 
the IAM moiety of the ICAT reagent. After equivalent samples were exposed to either 
control or oxidant conditions in a non-reducing environment, they are differentially labelled 
with the heavy or light form of the ICAT. The protein samples are mixed and then, with 
tryptic digestion, the labelled peptides are separated by affinity chromatography. Finally, 
the captured peptides are analysed by LC-MS/MS for the identification of the oxidant-
sensitive cysteine thiols. 
3.3 Shotgun proteomics 
At present, 2DE-based methods are gradually substituted by gel-free technologies, such as 
shotgun-proteomics strategies. Shotgun-proteomics refers to the direct analysis by MS/MS of 
proteolysed protein mixtures so as to rapidly generate a global profile of the protein 
complement within the mixture itself. This mixture is highly complex. A solution to overcome 
this is represented by alternative sample preparation strategies, which could be suitable for 
performing a preliminary enrichment of peptides containing redox-modified cysteines. Several 
methods have been developed for isolating peptides containing oxidised cysteines. One of 
these approaches designed for the specific enrichment of sulpho peptides in tryptic digests is 
based on anionic affinity capture using poly-arginine-coated nanodiamonds as high affinity 
probes (Aggarwal et al., 2006; Barrios-Llerena et al., 2006; Haas et al., 2006). 
4. Human diseases and early hints from redox proteomics 
Redox biology is key to the life sciences because an increasing number of cellular functions 
and impairments are found to be linked to redox processes. Accumulating evidence 
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suggests that a large number of diseases are closely related to oxidative stress. There is a 
growing need for the assessment of metabolic/oxidative stress and its modulation by the 
administration of pharmaceutical products. From a therapeutic point of view, drugs need to 
be designed to target oxidative stress sensitive biomarkers. In this context, redox proteomics 
might be pivotal in highlighting the main targets of protein oxidations and the biological 
pathways involved or compromised by these phenomena. Although the application of 
proteomics to drug design and development is in its earliest phase, preliminary redox 
proteomics results help to pave the way for further research in this field (D'Alessandro et al., 
2011).  
4.1 Neurodegenerative diseases 
Neurodegenerative diseases such as AD, PD and HD each have distinct clinical symptoms 
and pathologies: they all share common mechanisms, such as protein aggregation, oxidative 
injury, inflammation, apoptosis, and mitochondrial injury which all contribute to neuronal 
loss. In neurodegenerative diseases, ROS generated by dysfunctional mitochondria are 
known to have a strong impact on the cellular proteome. Redox proteomic analysis of the 
post-mortem brains of AD patients revealed the presence of oxidative modifications of 
various protein substrates. Among them, some are relevant mitochondrial proteins, such as 
ATP synthase ǂ- and ǃ-chain and VDAC(Robinson et al., 2011). These mitochondrial 
resident proteins were found to be oxidised in the hippocampus and the observed 
modifications could play a role in the mitochondrial dysfunction and cell death observed in 
AD. Extensive oxidative stress has also been detected in PD. It has been reported that ǂ-SYN 
was oxidised in the substantial nigra at the early stages of the disease. In addition, DJ-1 has 
been found to be modified by carbonylation and parkin to be S-nitrosylated, which results in 
a decrease of its E3 ligase activity. Several subunits of the respiratory complex I are 
subjected to oxidative damage, resulting in misassembling and the functional impairment of 
the complex. Redox proteomic analysis of HD R6/2 transgenic mice striatum revealed 
increased carbonyl levels in six proteins, including aconitase, creatine kinase and VDAC. 
Aconitase is an iron-sulphur protein that catalyses the isomerisation of citrate to isocitrate 
via cis-aconitate, and its inactivation may lead to an accumulation of reduced metabolites, 
such as NADH. The increased carbonyl levels, associated with the decreased activity of 
creatine kinase, could be relevant to the energetic impairments observed in HD (Sorolla et 
al., 2008). The role played by oxidative stress in ALS pathogenesis seems to be more relevant 
than in other neurodegenerative diseases. Oxidative damage induced oxidative 
modification of SOD1, UCHL-1 and Hsp70 proteins, which leads to the formation of SOD1 
aggregation (Sorolla et al., 2008; Sussmuth et al., 2008).  
Therefore, in the treatment of neurodegenerative diseases, neuroprotective agents which 
target ROS sources and aim at preventing their generation represent one class of drug 
therapeutics of great interest in pharmaceutical endeavours. Among them, the inhibitors of 
type B monoamine oxidase (such as selegiline and rasagiline) are the most promising 
neuroprotective agents to date, in that they prevent ROS generation. These inhibitors protect 
neuronal cells against cell death induced in cellular and animal models. The neuroprotective 
functions are ascribed to the stabilisation of mitochondria, the prevention of the death 
signalling process and the induction of the pro-survival anti-apoptotic Bcl-2 protein family 
and neurotrophic factors, thus counteracting mitochondria-mediated apoptotic pathways 
(Jones and Go, 2011).  
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4.2 Cardiovascular aging under oxidative stress 
Reactive oxygen species (ROS) play an important role in the pathologic genesis of 
cardiovascular disease. Vascular enzymes such as NADPH oxidases, xanthine oxidase and 
uncoupled endothelial nitric oxide synthase, are involved in the production of ROS. NO· is 
produced in endothelial cells by the activation of eNOS during the normal functioning of 
the vessel wall. Vasodilator hormones raise intracellular Ca2, leading to an increase in eNOS 
activity and NO· release. Physical forces such as fluid shear stress activate eNOS via protein 
kinase A- or Akt-dependent phosphorylation. The pathophysiological expression of 
inducible NOS in both macrophages and VSMCs elevates cytokine levels, resulting in 
localised inflammation. This, in turn, results in the production of NO· in the absence of 
further stimuli. Moreover, under some circumstances, eNOS becomes uncoupled and O2 and 
is made instead of NO. The NOS enzymes are thus potentially important sources of both 
NO and O2, depending on the surrounding environment. Virtually all types of vascular cells 
produce O2 and H2O2. In addition to mitochondrial sources of ROS, O2 and/or H2O2 can be 
made by many enzymes. Two of the most important sources in the normal vessel are 
thought to be cytochrome P450 and the membrane-associated NAD(P)H oxidase(s). A 
cytochrome P450 isozyme homologous to CYP 2C9 has been identified in coronary arteries 
and has been shown to produce O2 in response to bradykinin. NAD(P)H oxidases that are 
similar in structure to the neutrophil respiratory burst NADPH oxidase, but which produce 
less O2 for a longer time, have been identified in vascular cells. The endothelial, VSMC and 
fibroblast enzymes are not identical but have unique subunit structures and mechanisms of 
regulation. One important aspect of ROS production by at least the VSMC NAD(P)H 
oxidase is that it occurs largely intracellularly, making it ideally suited to modify signalling 
pathways and gene expression. The activity of the NAD(P)H oxidases can be modulated by 
vasoactive hormones and the small molecular weight G-protein rac-1. Angiotensin II, 
tumour necrosis factor-, thrombin and platelet-derived growth factor all increase oxidase 
activity and raise intracellular levels of O2 and H2O2 in VSMCs. Angiotensin II and 
lactosylceramide activate the endothelial cell enzyme, whereas fibroblasts increase O2 
production in response to angiotensin II, tumour necrosis factor-, interleukin-1 and the 
platelet-activating factor. Physical forces, including cell stretch, laminar shear stress and the 
disturbed oscillatory flow that occurs at branch points, are also potent activators of O2 
production in endothelial cells. There are two major mechanisms by which hormones and 
physical forces activate the NAD(P)H oxidase: (1) acutely, whereby the expressed enzyme is 
activated by phosphorylation, GTPase activity and production of the relevant lipid second 
messenger, and (2) chronically, when the expression of rate-limiting subunits of the enzyme 
is induced, thereby providing higher levels of enzyme susceptible to activation. 
Macrophages are perhaps the major vascular source of O2 in disease states. They oxidise 
LDL via the activation of diverse enzymes. Neutrophils and monocytes may also secrete 
myeloperoxidase, which appears to initiate lipid peroxidation. Two potential diffusible 
candidates to initiate myeloperoxidase dependent lipid peroxidation are the tyrosyl radical 
and nitrogen dioxide (NO2) (Elahi et al., 2009; Fearon and Faux, 2009; Lakshmi et al., 2009; 
Strobel et al., 2011). 
4.3 Aging and metabolism 
Early attempts at antioxidant intervention as a means to delay aging were initiated soon 
after the free radical theory of aging was proposed. These attempts stemmed from the 
postulation of the free radical theory of ageing which posits that the accumulation of 
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oxidative damage underlies the increased cellular, tissue and organ dysfunction and failure 
associated with advanced age.  
However, these antioxidant interventions have so far failed to extend life spans in most 
cases. At present, a series of encouraging - albeit preliminary - results have been reported in 
C. elegans and drosophila through the use of enzymatic synthetic drugs miming SOD and 
CAT activities, such as EUK-8 and EUK-134. However, while increasing antioxidant 
defences in these organisms, the drugs have not produced any significant increase in 
lifespan. Transgenic mice that constitutively over-express human CuZn-SOD did not live 
longer than control animals, while heterozygous mice with reduced MnSOD activity have a 
life expectancy that is similar to wild-type mice (although these animals have increased 
oxidative damage to their DNA). If free radicals are actually correlated to aging, a winning 
strategy should be targeted at preventing their production rather than increasing defences 
and repairing mechanisms against ROS-induced damages. The Mitochondrial Free Radical 
Theory of Aging (MFRTA) proposes that mitochondrial free radicals are the major source of 
oxidative damage. According to MFRTA, the accumulation of these oxidative phenomena is 
the main driving force in the aging process (Sanz and Stefanatos, 2008).  
Recent findings shed further light on the strong linkage between aging and metabolism and 
have opened brand new scenarios in the field of drug discovery. Insulin-like signalling in C. 
elegans activates the transcription factor SNK-1, which is known to defend against oxidative 
stress by mobilising the conserved phase 2 detoxification responses and it is thus referred to 
as the longevity-promoting factor. While aging remains a controversial issue, good results 
have been obtained in the field of cosmesis, as far as skin-aging is concerned. Antioxidant 
drug developments against skin aging have been extensively developed. A role has been 
proposed for ascorbic acid, alpha-tocopherol, carotenoids, polyphenols and other 
substances, such as ergothioneine, Zn(II)-glycine and CoQ10 in the treatment of skin-aging. 
In particular, the topical application of CoQ10 and antioxidants like alpha-glucosylrutin 
diminished resistance in the keratinocytes of old donors against UV irradiation, both in in 
vitro and in in vivo studies (D'Alessandro et al., 2011).  
5. Challenges to mapping the thiol proteome 
At present, mass spectrometry based proteomics makes rapid progress in mapping the Cys 
proteome (Chiappetta et al., 2011). These methods were also used to develop quantitative 
Cys proteomic databases and maps of redox systems biology. The full spectrum of Cys 
reactivity, such as glutathionylation, nitrosylation and other Cys modifications, needs to be 
analysed in order to address multiple modifications of the same Cys. Multiple modifications 
(e.g., products of benzene or acetaminophen oxidation) of a single Cys (e.g., C34 in albumin 
or Cb93 in haemoglobin) are used to identify chemical exposures. Links to chemical 
reactivity data, such as that provided by systematic comparisons of maleimide and 
iodoacetamide reactivity, would support an important chemical-biology interface which is 
currently lacking (Marino and Gladyshev, 2011).  
To address the entirety of the Cys proteome, there is a need to understand the fractional 
contribution of Cys with high and low reactivities. Considerable attention has been given to 
oxidation of the Cys proteome by H2O2. However, protein thiols can be oxidised by many 
other chemicals, including hydroperoxides, endoperoxides and quinones. CySS reacts 
slowly with GSH, but many protein Cys residues are much more reactive. Cys/CySS shuttle 
functions in the regulation of extracellular thiol/disulphide pools (Mannery et al., 2011).  
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An alternative possibility explaining the maintenance of cellular proteins under a non-
equilibrium, kinetically-controlled steady-state oxidation involves the pseudo-oxidase 
and/or pseudo-peroxidase activities of proteins. Very slow oxidative and peroxidative 
activities can be considered to be pseudo-oxidase and pseudo-peroxidase activities because 
the reaction rates and specificity for reactants are more similar to chemical reactions than to 
enzyme-catalysed reactions. Such reactions can depend upon low levels of associated 
metals, such as Cu2+ and Fe3+. For instance, Cu2+ can catalyse the oxidation of thiols in the 
presence of O2, resulting in thiol oxidation to a sulphenic acid or disulphide. Reduction back 
to a thiol by TRX or GSH would complete a pseudo-oxidase cycle. At low rates of oxidation 
of the Cys proteome where ongoing cellular H2O2 generation occurs by other mechanisms, 
such a reaction sequence is difficult to verify. Earlier studies showed that H2O2 production 
in cellular fractions increases in proportion to O2 partial pressure, and that protein oxidation 
occurs as a function of cellular iron and copper. Consequently, for the development of redox 
maps of the Cys proteome, additional information will be needed regarding the contribution 
of reactions of Cys at relevant, slow biologic reaction rates so that the system descriptions 
will adequately interpret reaction rates in systems biology models (Jones and Go, 2011). 
6. Conclusion 
Redox regulation is a fundamental physiological process which plays an important role in 
pathophysiological events. It is via reversible thiol modification that transcriptional and 
posttranslational responses are triggered. At present, an increasing number of techniques 
have been developed that make it possible to investigate, either qualitatively or 
quantitatively, modifications to specific amino acids (cysteines, tyrosines, etc.) or specific 
groups (carbonylations, nitrosylations, etc.). Redox proteomics is a powerful tool for 
monitoring physiological changes under oxidative stress. The identification of redox 
regulated proteins will provide great help in directing drug design and administration, new 
therapeutic targets and their validation. Currently, an accurate quantification of oxidised 
proteins remains difficult. A major task for future proteomics studies will be to develop 
tools to identify the different types of oxidation forms and establish the means to quantify 
the extent of such modification. 
7. Acknowledgements 
This work was supported by the National Basic Research Program of China (973 program, 
2011CB711003), State Key Lab of Space Medicine Fundamentals and Application grants 
(SMFA1002), National Natural Science Foundation of China Project (31170811，31000386). 
8. References 
Aggarwal, K., Choe, L.H. and Lee, K.H. (2006) Shotgun proteomics using the iTRAQ 
isobaric tags. Brief Funct Genomic Proteomic, 5, 112-120. 
Avellini, C., Baccarani, U., Trevisan, G., Cesaratto, L., Vascotto, C., D'Aurizio, F., Pandolfi, 
M., Adani, G.L. and Tell, G. (2007) Redox proteomics and immunohistology to 
study molecular events during ischemia-reperfusion in human liver. Transplant 
Proc, 39, 1755-1760. 
www.intechopen.com
 
Protein Thiol Modification and Thiol Proteomics 389 
Barrios-Llerena, M.E., Chong, P.K., Gan, C.S., Snijders, A.P., Reardon, K.F. and Wright, P.C. 
(2006) Shotgun proteomics of cyanobacteria--applications of experimental and 
data-mining techniques. Brief Funct Genomic Proteomic, 5, 121-132. 
Buczek, O., Green, B.R. and Bulaj, G. (2007) Albumin is a redox-active crowding agent that 
promotes oxidative folding of cysteine-rich peptides. Biopolymers, 88, 8-19. 
Butterfield, D.A. and Sultana, R. (2007) Redox proteomics identification of oxidatively 
modified brain proteins in Alzheimer's disease and mild cognitive impairment: 
insights into the progression of this dementing disorder. J Alzheimers Dis, 12, 61-72. 
Byun, M.S., Jeon, K.I., Choi, J.W., Shim, J.Y. and Jue, D.M. (2002) Dual effect of oxidative 
stress on NF-kappakB activation in HeLa cells. Exp Mol Med, 34, 332-339. 
Carlier, M.F. (1991) Actin: protein structure and filament dynamics. J Biol Chem, 266, 1-4. 
Chiappetta, G., Ndiaye, S., Igbaria, A., Kumar, C., Vinh, J. and Toledano, M.B. (2011) 
Proteome screens for Cys residues oxidation: the redoxome. Methods Enzymol, 473, 
199-216. 
D'Alessandro, A., Rinalducci, S. and Zolla, L. (2011) Redox proteomics and drug 
development. J Proteomics, [Epub ahead of print]. 
Dalle-Donne, I., Carini, M., Vistoli, G., Gamberoni, L., Giustarini, D., Colombo, R., Maffei 
Facino, R., Rossi, R., Milzani, A. and Aldini, G. (2007) Actin Cys374 as a 
nucleophilic target of alpha,beta-unsaturated aldehydes. Free Radic Biol Med, 42, 
583-598. 
Damdimopoulos, A.E., Miranda-Vizuete, A., Pelto-Huikko, M., Gustafsson, J.A. and Spyrou, 
G. (2002) Human mitochondrial thioredoxin. Involvement in mitochondrial 
membrane potential and cell death. J Biol Chem, 277, 33249-33257. 
Dietz, K.J. (2003) Redox control, redox signaling, and redox homeostasis in plant cells. Int 
Rev Cytol, 228, 141-193. 
Elahi, M.M., Kong, Y.X. and Matata, B.M. (2009) Oxidative stress as a mediator of 
cardiovascular disease. Oxid Med Cell Longev, 2, 259-269. 
Fearon, I.M. and Faux, S.P. (2009) Oxidative stress and cardiovascular disease: novel tools 
give (free) radical insight. J Mol Cell Cardiol, 47, 372-381. 
Fiaschi, T., Cozzi, G., Raugei, G., Formigli, L., Ramponi, G. and Chiarugi, P. (2006) Redox 
regulation of beta-actin during integrin-mediated cell adhesion. J Biol Chem, 281, 
22983-22991. 
Francavilla, A., Hagiya, M., Porter, K.A., Polimeno, L., Ihara, I. and Starzl, T.E. (1994) 
Augmenter of liver regeneration: its place in the universe of hepatic growth factors. 
Hepatology, 20, 747-757. 
Haas, W., Faherty, B.K., Gerber, S.A., Elias, J.E., Beausoleil, S.A., Bakalarski, C.E., Li, X., 
Villen, J. and Gygi, S.P. (2006) Optimization and use of peptide mass measurement 
accuracy in shotgun proteomics. Mol Cell Proteomics, 5, 1326-1337. 
Haendeler, J., Hoffmann, J., Tischler, V., Berk, B.C., Zeiher, A.M. and Dimmeler, S. (2002) 
Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-
nitrosylation at cysteine 69. Nat Cell Biol, 4, 743-749. 
Hagiya, M., Francavilla, A., Polimeno, L., Ihara, I., Sakai, H., Seki, T., Shimonishi, M., Porter, 
K.A. and Starzl, T.E. (1994) Cloning and sequence analysis of the rat augmenter of 
liver regeneration (ALR) gene: expression of biologically active recombinant ALR 
and demonstration of tissue distribution. Proc Natl Acad Sci U S A, 91, 8142-8146. 
www.intechopen.com
 
Integrative Proteomics 390 
Hofhaus, G., Lee, J.E., Tews, I., Rosenberg, B. and Lisowsky, T. (2003) The N-terminal 
cysteine pair of yeast sulfhydryl oxidase Erv1p is essential for in vivo activity and 
interacts with the primary redox centre. Eur J Biochem, 270, 1528-1535. 
Hoober, K.L., Sheasley, S.L., Gilbert, H.F. and Thorpe, C. (1999) Sulfhydryl oxidase from egg 
white. A facile catalyst for disulfide bond formation in proteins and peptides. J Biol 
Chem, 274, 22147-22150. 
Jeon, K.I., Byun, M.S. and Jue, D.M. (2003) Gold compound auranofin inhibits IkappaB 
kinase (IKK) by modifying Cys-179 of IKKbeta subunit. Exp Mol Med, 35, 61-66. 
Jones, D.P. and Go, Y.M. (2011) Mapping the cysteine proteome: analysis of redox-sensing 
thiols. Curr Opin Chem Biol, 15, 103-112. 
Kalinina, E.V., Chernov, N.N. and Saprin, A.N. (2008) Involvement of thio-, peroxi-, and 
glutaredoxins in cellular redox-dependent processes. Biochemistry (Mosc), 73, 1493-
1510. 
Klemke, M., Wabnitz, G.H., Funke, F., Funk, B., Kirchgessner, H. and Samstag, Y. (2008) 
Oxidation of cofilin mediates T cell hyporesponsiveness under oxidative stress 
conditions. Immunity, 29, 404-413. 
Lakshmi, S.V., Padmaja, G., Kuppusamy, P. and Kutala, V.K. (2009) Oxidative stress in 
cardiovascular disease. Indian J Biochem Biophys, 46, 421-440. 
Lassing, I., Schmitzberger, F., Bjornstedt, M., Holmgren, A., Nordlund, P., Schutt, C.E. and 
Lindberg, U. (2007) Molecular and structural basis for redox regulation of beta-
actin. J Mol Biol, 370, 331-348. 
Lemaire, S.D., Quesada, A., Merchan, F., Corral, J.M., Igeno, M.I., Keryer, E., Issakidis-
Bourguet, E., Hirasawa, M., Knaff, D.B. and Miginiac-Maslow, M. (2005) NADP-
malate dehydrogenase from unicellular green alga Chlamydomonas reinhardtii. A 
first step toward redox regulation? Plant Physiol, 137, 514-521. 
Li, Y., Liu, W., Xing, G., Tian, C., Zhu, Y. and He, F. (2005) Direct association of 
hepatopoietin with thioredoxin constitutes a redox signal transduction in activation 
of AP-1/NF-kappaB. Cell Signal, 17, 985-996. 
Lisowsky, T., Lee, J.E., Polimeno, L., Francavilla, A. and Hofhaus, G. (2001) Mammalian 
augmenter of liver regeneration protein is a sulfhydryl oxidase. Dig Liver Dis, 33, 
173-180. 
Mannery, Y.O., Ziegler, T.R., Hao, L., Shyntum, Y. and Jones, D.P. (2011) Characterization of 
apical and basal thiol-disulfide redox regulation in human colonic epithelial cells. 
Am J Physiol Gastrointest Liver Physiol, 299, G523-530. 
Marcotte, E.M., Pellegrini, M., Ng, H.L., Rice, D.W., Yeates, T.O. and Eisenberg, D. (1999a) 
Detecting protein function and protein-protein interactions from genome 
sequences. Science, 285, 751-753. 
Marcotte, E.M., Pellegrini, M., Thompson, M.J., Yeates, T.O. and Eisenberg, D. (1999b) A 
combined algorithm for genome-wide prediction of protein function. Nature, 402, 
83-86. 
Marino, S.M. and Gladyshev, V.N. (2011) Proteomics: mapping reactive cysteines. Nat Chem 
Biol, 7, 72-73. 
McDonagh, B. and Sheehan, D. (2008) Effects of oxidative stress on protein thiols and 
disulphides in Mytilus edulis revealed by proteomics: actin and protein disulphide 
isomerase are redox targets. Mar Environ Res, 66, 193-195. 
www.intechopen.com
 
Protein Thiol Modification and Thiol Proteomics 391 
Nakashima, I., Kato, M., Akhand, A.A., Suzuki, H., Takeda, K., Hossain, K. and Kawamoto, 
Y. (2002) Redox-linked signal transduction pathways for protein tyrosine kinase 
activation. Antioxid Redox Signal, 4, 517-531. 
Nishiyama, A., Masutani, H., Nakamura, H., Nishinaka, Y. and Yodoi, J. (2001) Redox 
regulation by thioredoxin and thioredoxin-binding proteins. IUBMB Life, 52, 29-33. 
Poerschke, R.L. and Moos, P.J. (2011) Thioredoxin reductase 1 knockdown enhances 
selenazolidine cytotoxicity in human lung cancer cells via mitochondrial 
dysfunction. Biochem Pharmacol, 81, 211-221. 
Robinson, R.A., Lange, M.B., Sultana, R., Galvan, V., Fombonne, J., Gorostiza, O., Zhang, J., 
Warrier, G., Cai, J., Pierce, W.M., Bredesen, D.E. and Butterfield, D.A. (2011) 
Differential expression and redox proteomics analyses of an Alzheimer disease 
transgenic mouse model: effects of the amyloid-beta peptide of amyloid precursor 
protein(Xi). Neuroscience, 177, 207-222. 
Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., 
Miyazono, K. and Ichijo, H. (1998) Mammalian thioredoxin is a direct inhibitor of 
apoptosis signal-regulating kinase (ASK) 1. Embo J, 17, 2596-2606. 
Salsbury, F.R., Jr., Knutson, S.T., Poole, L.B. and Fetrow, J.S. (2008) Functional site profiling 
and electrostatic analysis of cysteines modifiable to cysteine sulfenic acid. Protein 
Sci, 17, 299-312. 
Sanz, A. and Stefanatos, R.K. (2008) The mitochondrial free radical theory of aging: a critical 
view. Curr Aging Sci, 1, 10-21. 
Sen, C.K. (1998) Redox signaling and the emerging therapeutic potential of thiol 
antioxidants. Biochem Pharmacol, 55, 1747-1758. 
Sen, C.K. (2000) Cellular thiols and redox-regulated signal transduction. Curr Top Cell Regul, 
36, 1-30. 
Senkevich, T.G., White, C.L., Koonin, E.V. and Moss, B. (2000) A viral member of the 
ERV1/ALR protein family participates in a cytoplasmic pathway of disulfide bond 
formation. Proc Natl Acad Sci U S A, 97, 12068-12073. 
Sethuraman, M., McComb, M.E., Huang, H., Huang, S., Heibeck, T., Costello, C.E. and 
Cohen, R.A. (2004) Isotope-coded affinity tag (ICAT) approach to redox 
proteomics: identification and quantitation of oxidant-sensitive cysteine thiols in 
complex protein mixtures. J Proteome Res, 3, 1228-1233. 
Smeets, A., Evrard, C., Landtmeters, M., Marchand, C., Knoops, B. and Declercq, J.P. (2005) 
Crystal structures of oxidized and reduced forms of human mitochondrial 
thioredoxin 2. Protein Sci, 14, 2610-2621. 
Sorolla, M.A., Reverter-Branchat, G., Tamarit, J., Ferrer, I., Ros, J. and Cabiscol, E. (2008) 
Proteomic and oxidative stress analysis in human brain samples of Huntington 
disease. Free Radic Biol Med, 45, 667-678. 
Strobel, N.A., Fassett, R.G., Marsh, S.A. and Coombes, J.S. (2011) Oxidative stress 
biomarkers as predictors of cardiovascular disease. Int J Cardiol, 147, 191-201. 
Sussmuth, S.D., Brettschneider, J., Ludolph, A.C. and Tumani, H. (2008) Biochemical 
markers in CSF of ALS patients. Curr Med Chem, 15, 1788-1801. 
Wang, X., Ling, S., Zhao, D., Sun, Q., Li, Q., Wu, F., Nie, J., Qu, L., Wang, B., Shen, X., Bai, Y., 
Li, Y. and Li, Y. (2010) Redox regulation of actin by thioredoxin-1 is mediated by 
the interaction of the proteins via cysteine 62. Antioxid Redox Signal, 13, 565-573. 
www.intechopen.com
 
Integrative Proteomics 392 
Watson, W.H., Pohl, J., Montfort, W.R., Stuchlik, O., Reed, M.S., Powis, G. and Jones, D.P. 
(2003) Redox potential of human thioredoxin 1 and identification of a second 
dithiol/disulfide motif. J Biol Chem, 278, 33408-33415. 
Xanthoudakis, S., Miao, G., Wang, F., Pan, Y.C. and Curran, T. (1992) Redox activation of 
Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. Embo J, 11, 
3323-3335. 
www.intechopen.com
Integrative Proteomics
Edited by Dr. Hon-Chiu Leung
ISBN 978-953-51-0070-6
Hard cover, 442 pages
Publisher InTech
Published online 24, February, 2012
Published in print edition February, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Proteomics was thought to be a natural extension after the field of genomics has deposited significant amount
of data. However, simply taking a straight verbatim approach to catalog all proteins in all tissues of different
organisms is not viable. Researchers may need to focus on the perspectives of proteomics that are essential
to the functional outcome of the cells. In Integrative Proteomics, expert researchers contribute both historical
perspectives, new developments in sample preparation, gel-based and non-gel-based protein separation and
identification using mass spectrometry. Substantial chapters are describing studies of the sub-proteomes such
as phosphoproteome or glycoproteomes which are directly related to functional outcomes of the cells.
Structural proteomics related to pharmaceutics development is also a perspective of the essence.
Bioinformatics tools that can mine proteomics data and lead to pathway analyses become an integral part of
proteomics. Integrative proteomics covers both look-backs and look-outs of proteomics. It is an ideal reference
for students, new researchers, and experienced scientists who want to get an overview or insights into new
development of the proteomics field.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Yingxian Li, Xiaogang Wang and Qi Li (2012). Protein Thiol Modification and Thiol Proteomics, Integrative
Proteomics, Dr. Hon-Chiu Leung (Ed.), ISBN: 978-953-51-0070-6, InTech, Available from:
http://www.intechopen.com/books/integrative-proteomics/protein-thiol-modification-and-thiol-proteomics
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
